Literature DB >> 27317879

Seroepidemiological survey of hepatitis B virus infection among 764,460 women of childbearing age in rural China: A cross-sectional study.

Xiaona Xin1, Yuanyuan Wang2, Jun Cheng3, Ya Zhang4, Zuoqi Peng5, Jihong Xu6, Ying Yang7, Yuan He8, Xu Ma9.   

Abstract

BACKGROUND: China has historically been a highly endemic area for hepatitis B infection. Progress has been made in tackling the disease in infants and children, but infection rates remain high in adults, especially in rural areas. Current data on the prevalence of HBV in women of childbearing age is lacking.
OBJECTIVES: We analyzed the HBV serological status of women of childbearing age in rural China to provide data to inform the development of prevention and control measures for hepatitis B. STUDY
DESIGN: Questionnaires and serum samples have been collected from rural couples aged 20-49 years in 292 counties in 2014. ELISA methods were employed to detect serum HBV markers.
RESULTS: From January to December 2014, 771,567 questionnaires and 764,460 blood samples were collected. Among these, 44,057 (5.76%) women tested positive for HBsAg and 100,519 (13.24%) tested positive for anti-HBc. In this sub group, 39,862 (39.66%) women also tested positive for HBsAg. There were 338,528 (41.67%) tested positive for anti-HBs and single anti-HBs presented in 259,800 (33.98%) women. In total, 385,140 (50.38%) tested negative for all HBV markers. Of the HBsAg positive participants, 12,520 (28.42%) were positive for both HBsAg and HBeAg, and therefore infectious although this declined with age (P<0.001). Prevalence of HBsAg positivity was highest in the 'eastern' region (P<0.001).
CONCLUSIONS: HBV prevalence among women of childbearing age in rural China has declined compared to the 2006 National study of women aged 15-59 years (5.76 vs. 6.73%), but remains high.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27317879     DOI: 10.1016/j.jcv.2016.05.014

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

1.  Modelling the prevalence of hepatitis B towards eliminating it as a major public health threat in China.

Authors:  Wenjun Liu; Tianyi Zhuang; Ruyi Xia; Zhuoru Zou; Lei Zhang; Mingwang Shen; Guihua Zhuang
Journal:  BMC Public Health       Date:  2022-06-13       Impact factor: 4.135

2.  Conventional and genetic risk factors for chronic Hepatitis B virus infection in a community-based study of 0.5 million Chinese adults.

Authors:  Elizabeth Hamilton; Ling Yang; Alexander J Mentzer; Yu Guo; Yiping Chen; Jun Lv; Robert Fletcher; Neil Wright; Kuang Lin; Robin Walters; Christiana Kartsonaki; Yingcai Yang; Sushila Burgess; Sam Sansome; Liming Li; Iona Y Millwood; Zhengming Chen
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

3.  Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.

Authors:  Tianyu He; Yuqing Bai; Haodong Cai; Xiaojuan Ou; Min Liu; Wei Yi; Jidong Jia
Journal:  Hepatol Int       Date:  2018-01-17       Impact factor: 6.047

4.  Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China.

Authors:  Yuanyuan Wang; Hong Zhou; Long Zhang; Qiuyue Zhong; Qiaomei Wang; Haiping Shen; Man Zhang; Yanjie Huang; Anqi Wang; Kenrad Nelson; Yiping Zhang; Donghai Yan; Zuoqi Peng; Ya Zhang; Xiaona Xin; Hongguang Zhang; Jun Zhao; Yan Wang; Ying Yang; Yuan He; Jihong Xu; Xiaoli Liu; Yan Wang; Xu Ma
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

5.  A cross-sectional survey on the rate of awareness of hepatitis B virus (HBV) infection and the prevention of mother-to-child transmission among hepatitis B surface antigen (HBsAg)-positive pregnant women.

Authors:  Zhaodi Huang; Ting Liu; Yanxiang Qin; Jianying Chen; Zhenghong Ou; Xiaohui Min
Journal:  Ann Transl Med       Date:  2022-07

6.  Effect of a Community-Based Hepatitis B Virus Infection Detection Combined with Vaccination Program in China.

Authors:  Xinyao Liu; Wuqi Qiu; Yan Liang; Wei Zhang; Qian Qiu; Xinxin Bai; Guolin Dai; Hao Ma; Hongpu Hu; Wei Zhao; Guangyu Hu
Journal:  Vaccines (Basel)       Date:  2021-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.